Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

299 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production.
Chen L, Shi V, Wang S, Sun L, Freeman R, Yang J, Inkman MJ, Ghosh S, Ruiz F, Jayachandran K, Huang Y, Luo J, Zhang J, Cosper P, Luke CJ, Spina CS, Grigsby PW, Schwarz JK, Markovina S. Chen L, et al. Among authors: grigsby pw. J Clin Invest. 2023 Aug 1;133(15):e163841. doi: 10.1172/JCI163841. J Clin Invest. 2023. PMID: 37279067 Free PMC article.
SCCA1/SERPINB3 promotes suppressive immune environment via STAT-dependent chemokine production, blunting the therapy-induced T cell responses.
Chen L, Shi V, Wang S, Freeman R, Ruiz F, Jayachandran K, Zhang J, Cosper P, Sun L, Luke CJ, Spina C, Grigsby PW, Schwarz JK, Markovina S. Chen L, et al. Among authors: grigsby pw. bioRxiv [Preprint]. 2023 Feb 3:2023.02.01.526675. doi: 10.1101/2023.02.01.526675. bioRxiv. 2023. PMID: 36778224 Free PMC article. Preprint.
Overall survival in patients with FIGO stage IVA cervical cancer.
Schiff JP, Mintz R, Cohen AC, Huang Y, Thaker P, Massad LS, Powell M, Mutch D, Schwarz JK, Markovina ST, Grigsby PW. Schiff JP, et al. Among authors: grigsby pw. Gynecol Oncol. 2022 Aug;166(2):292-299. doi: 10.1016/j.ygyno.2022.05.022. Epub 2022 Jun 10. Gynecol Oncol. 2022. PMID: 35691754
Management and prognosis of cervical cancer patients treated with definitive radiation therapy who have partial metabolic response on post-therapy positron emission tomography.
Mckinnish TR, Greenwade MM, Wilkinson-Ryan I, Schwarz JK, Powell MA, Mutch DG, Massad LS, Grigsby PW, Siegel BA, Thaker PH. Mckinnish TR, et al. Among authors: grigsby pw. Gynecol Oncol. 2022 Jul;166(1):173-180. doi: 10.1016/j.ygyno.2022.04.018. Epub 2022 May 7. Gynecol Oncol. 2022. PMID: 35537885
Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas.
Ruiz FJ, Sundaresan A, Zhang J, Pedamallu CS, Halle MK, Srinivasasainagendra V, Zhang J, Muhammad N, Stanley J, Markovina S, Tiwari HK, Grigsby PW, Krakstad C, Schwarz JK, Ojesina AI. Ruiz FJ, et al. Among authors: grigsby pw. Cancers (Basel). 2021 Sep 10;13(18):4551. doi: 10.3390/cancers13184551. Cancers (Basel). 2021. PMID: 34572780 Free PMC article.
Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer.
Henke LE, Stanley JA, Robinson C, Srivastava A, Contreras JA, Curcuru A, Green OL, Massad LS, Kuroki L, Fuh K, Hagemann A, Mutch D, McCourt C, Thaker P, Powell M, Markovina S, Grigsby PW, Schwarz JK, Chundury A. Henke LE, et al. Among authors: grigsby pw. Int J Radiat Oncol Biol Phys. 2022 Feb 1;112(2):379-389. doi: 10.1016/j.ijrobp.2021.08.033. Epub 2021 Aug 30. Int J Radiat Oncol Biol Phys. 2022. PMID: 34474109 Clinical Trial.
299 results